Syngene International to Invest $56 Million in Syngene USA for Strategic Expansion

Unknown Apr 02, 2026 1,050 Views

Syngene International Ltd has announced an additional investment of up to $56 million in its wholly owned subsidiary, Syngene USA Inc. The funds will support the acquisition of a biologics facility in Baltimore and meet operational needs. This move strengthens Syngene’s foothold in the U.S....

Stay Ahead – Explore Now! ECL Expands Healthcare Network in Coal Belt to Boost 'Swasth Bharat'